Balance Labs, Inc. Logo

Balance Labs, Inc.

BLNC

(1.8)
Stock Price

0,18 USD

-211.28% ROA

15.96% ROE

-7.43x PER

Market Cap.

5.093.390,00 USD

-55.9% DER

0% Yield

-1522.72% NPM

Balance Labs, Inc. Stock Analysis

Balance Labs, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Balance Labs, Inc. Fundamental Stock Analysis
# Analysis Rating
1 ROE

The stock's ROE exceeds expectations (15.96%), revealing strong profitability and efficient use of shareholders' equity, making it an attractive investment opportunity.

2 PBV

With a remarkably low PBV ratio (-1.15x), the stock offers substantial upside potential at a bargain price.

3 DER

The stock has a low debt to equity ratio (-6%), which means it has a small amount of debt compared to the ownership it holds

4 Graham Number

The Graham number calculation reveals that this company's stock price is potentially underestimated, implying that it may be a promising investment option.

5 ROA

The stock's ROA (-211.28%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

6 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

7 Net Profit Growth

This company's net profit has remained flat over the past five years, suggesting a lack of growth and making it a less attractive investment opportunity.

8 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

9 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

10 Dividend

The company's decision to withhold dividends for three years raises questions about its ability to generate consistent returns.

11 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is overpriced (0), presenting a possible disadvantage for investors as its market price surpasses its estimated intrinsic value.

Balance Labs, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Balance Labs, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Buy
4 Stoch RSI Buy

Balance Labs, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Balance Labs, Inc. Revenue
Year Revenue Growth
2014 111.000
2015 39.000 -184.62%
2016 0 0%
2017 500 100%
2018 6.667 92.5%
2019 3.333 -100.03%
2020 1.000.000 99.67%
2021 624.590 -60.11%
2022 247.500 -152.36%
2023 0 0%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Balance Labs, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2014 0
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Balance Labs, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2014 119.650
2015 402.446 70.27%
2016 670.033 39.94%
2017 303.606 -120.69%
2018 609.722 50.21%
2019 561.275 -8.63%
2020 387.494 -44.85%
2021 400.164 3.17%
2022 270.336 -48.02%
2023 137.916 -96.01%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Balance Labs, Inc. EBITDA
Year EBITDA Growth
2014 -8.250
2015 -363.446 97.73%
2016 -668.706 45.65%
2017 -530.678 -26.01%
2018 -599.519 11.48%
2019 -678.855 11.69%
2020 518.156 231.01%
2021 265.170 -95.41%
2022 -66.780 497.08%
2023 -137.916 51.58%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Balance Labs, Inc. Gross Profit
Year Gross Profit Growth
2014 111.000
2015 39.000 -184.62%
2016 0 0%
2017 -231.003 100%
2018 6.667 3564.87%
2019 3.333 -100.03%
2020 1.000.000 99.67%
2021 624.590 -60.11%
2022 247.500 -152.36%
2023 0 0%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Balance Labs, Inc. Net Profit
Year Net Profit Growth
2014 -8.450
2015 -365.900 97.69%
2016 -1.134.655 67.75%
2017 -838.577 -35.31%
2018 -547.678 -53.11%
2019 -929.445 41.07%
2020 246.429 477.17%
2021 -1.027.396 123.99%
2022 -1.282.195 19.87%
2023 -274.940 -366.35%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Balance Labs, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2014 0
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Balance Labs, Inc. Free Cashflow
Year Free Cashflow Growth
2014 65.550
2015 -202.602 132.35%
2016 -645.053 68.59%
2017 -372.332 -73.25%
2018 -424.441 12.28%
2019 -365.608 -16.09%
2020 -218.002 -67.71%
2021 -66.396 -228.34%
2022 7.753 956.39%
2023 -36.782 121.08%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Balance Labs, Inc. Operating Cashflow
Year Operating Cashflow Growth
2014 65.550
2015 -202.602 132.35%
2016 -635.073 68.1%
2017 -372.332 -70.57%
2018 -420.269 11.41%
2019 -365.608 -14.95%
2020 -218.002 -67.71%
2021 -56.896 -283.16%
2022 7.753 833.86%
2023 -36.782 121.08%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Balance Labs, Inc. Capital Expenditure
Year Capital Expenditure Growth
2014 0
2015 0 0%
2016 9.980 100%
2017 0 0%
2018 4.172 100%
2019 0 0%
2020 0 0%
2021 9.500 100%
2022 0 0%
2023 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Balance Labs, Inc. Equity
Year Equity Growth
2014 -6.447
2015 -242.342 97.34%
2016 126.181 292.06%
2017 -1.524.646 108.28%
2018 -2.113.109 27.85%
2019 -2.938.014 28.08%
2020 -2.587.356 -13.55%
2021 -3.392.961 23.74%
2022 -4.161.312 18.46%
2023 -4.414.080 5.73%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Balance Labs, Inc. Assets
Year Assets Growth
2014 66.658
2015 22.722 -193.36%
2016 955.233 97.62%
2017 121.402 -686.83%
2018 314.864 61.44%
2019 237.421 -32.62%
2020 1.270.384 81.31%
2021 1.014.551 -25.22%
2022 429.119 -136.43%
2023 324.320 -32.31%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Balance Labs, Inc. Liabilities
Year Liabilities Growth
2014 73.105
2015 265.064 72.42%
2016 829.052 68.03%
2017 1.646.048 49.63%
2018 2.427.973 32.2%
2019 3.175.435 23.54%
2020 3.857.740 17.69%
2021 4.407.512 12.47%
2022 4.590.431 3.98%
2023 4.738.400 3.12%

Balance Labs, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
-0.03
Price to Earning Ratio
-7.43x
Price To Sales Ratio
113.19x
POCF Ratio
-38.25
PFCF Ratio
-38.25
Price to Book Ratio
-1.15
EV to Sales
164.78
EV Over EBITDA
-51.83
EV to Operating CashFlow
-55.69
EV to FreeCashFlow
-55.69
Earnings Yield
-0.13
FreeCashFlow Yield
-0.03
Market Cap
0,01 Bil.
Enterprise Value
0,01 Bil.
Graham Number
0.38
Graham NetNet
-0.2

Income Statement Metrics

Net Income per Share
-0.03
Income Quality
0.3
ROE
0.16
Return On Assets
-2.11
Return On Capital Employed
0.03
Net Income per EBT
1.53
EBT Per Ebit
3.55
Ebit per Revenue
-2.81
Effective Tax Rate
-0.56

Margins

Sales, General, & Administrative to Revenue
3.93
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.27
Operating Profit Margin
-2.81
Pretax Profit Margin
-9.98
Net Profit Margin
-15.23

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.01
Free CashFlow per Share
-0.01
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
0.1
Return on Tangible Assets
-2.11
Days Sales Outstanding
0
Days Payables Outstanding
0
Days of Inventory on Hand
0
Receivables Turnover
0
Payables Turnover
0
Inventory Turnover
0
Capex per Share
0

Balance Sheet

Cash per Share
0,01
Book Value per Share
-0,20
Tangible Book Value per Share
-0.2
Shareholders Equity per Share
-0.2
Interest Debt per Share
0.12
Debt to Equity
-0.56
Debt to Assets
7.61
Net Debt to EBITDA
-16.23
Current Ratio
0.08
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
-0.56
Working Capital
0,00 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
0
Debt to Market Cap
0.48

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Balance Labs, Inc. Dividends
Year Dividends Growth

Balance Labs, Inc. Profile

About Balance Labs, Inc.

Balance Labs, Inc. operates as a consulting firm that provides business development and consulting services to startup and development-stage businesses in the United States and internationally. The company offers services that help businesses in various industries to improve and fine tune their business models, sales and marketing plans, and internal operations, as well as make introduction to professional services, such as business plan writing, accounting firms, and legal service providers. It also assists in the development and execution of various services, such as business model development, including marketing research, naming, and branding; financial modeling; Website and mobile app development; employee and board member recruitment; patent/trademark filing assistance; product or service development; product production; marketing material development; product or service placement; celebrity endorsements; and introductions to professional services, such as legal and accounting. The company was incorporated in 2014 and is based in Miami Beach, Florida. Balance Labs, Inc. is a subsidiary of Balance Holdings, LLC.

CEO
Mr. Michael D. Farkas
Employee
4
Address
350 Lincoln Road
Miami Beach, 33139

Balance Labs, Inc. Executives & BODs

Balance Labs, Inc. Executives & BODs
# Name Age
1 Mr. Michael D. Farkas
President, Chief Executive Officer & Chairman
70
2 Ms. Carmen Villegas
Secretary & Director
70
3 Mr. Ari Feldman
Chief Financial Officer
70

Balance Labs, Inc. Competitors